Journal
JOURNAL OF ASTHMA AND ALLERGY
Volume 14, Issue -, Pages 1209-1215Publisher
DOVE MEDICAL PRESS LTD
DOI: 10.2147/JAA.S333098
Keywords
anaphylaxis; COVID-19 vaccine; drug allergy; excipient; vaccine allergy; COVID-19; skin testing
Categories
Ask authors/readers for more resources
Anaphylaxis to CoronaVac is extremely rare, but can be diagnosed and treated through skin testing and graded vaccine challenges if it occurs.
Anaphylaxis to CoronaVac, an inactivated vaccine against COVID-19, is extremely rare. We report 12 cases of anaphylaxis after CoronaVac administration, focusing on clinical characteristics and management outcomes. Skin test and graded vaccine challenge were successfully performed in our cases and might be considered if an inactivated vaccine is the only remaining option.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
